Mlak, R., Krawczyk, P., Ciesielka, M., Homa, I., Powrózek, T., Prendecka, M., . . . Małecka-Massalska, T. (2015). Predictive value of STMN1 gene promoter polymorphism (−2166T>C) in patients with advanced NSCLC treated with the combination of platinum compounds and vinorelbine. Cancer Chemother Pharmacol.

Mlak, Radosław, Paweł Krawczyk, Marzanna Ciesielka, Iwona Homa, Tomasz Powrózek, Monika Prendecka, Piotr Kozioł, Janusz Milanowski, and Teresa Małecka-Massalska. "Predictive Value of STMN1 Gene Promoter Polymorphism (−2166T>C) in Patients With Advanced NSCLC Treated With the Combination of Platinum Compounds and Vinorelbine." Cancer Chemother Pharmacol 2015.

Mlak, Radosław, et al. "Predictive Value of STMN1 Gene Promoter Polymorphism (−2166T>C) in Patients With Advanced NSCLC Treated With the Combination of Platinum Compounds and Vinorelbine." Cancer Chemother Pharmacol 2015.